Attention to Infliximab adverse events: chimeric monoclonal antibodies can induce anti chimeric antibodies that may result in Kounis hypersensitivity associated acute coronary syndrome.

Eur Rev Med Pharmacol Sci

Published: April 2015

Download full-text PDF	Source

Publication Analysis

attention infliximab

infliximab adverse

adverse events

events chimeric

chimeric monoclonal

monoclonal antibodies

antibodies induce

induce anti

anti chimeric

chimeric antibodies

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!